moxalactam has been researched along with cefotetan in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (72.73) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Grime, K; Paine, SW | 1 |
Freimer, EH; Ingalls, CS | 1 |
Deguchi, K; Fukayama, S; Fukushima, Y; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Hejmanowski, LG; Rigan, D; Schentag, JJ; Walawander, C; Welage, LS; Williams, JS; Wilton, JH | 1 |
Adelman, MH; Grasela, TH; Rigan, D; Schentag, JJ; Welage, LS; Williams, JS; Wilton, JH | 1 |
Wilson, SE | 2 |
Castillo, J; Gil, J; Gomez-Lus, ML; Gomez-Lus, R; Otal, I; Rubio, MC; Sarraseca, C | 1 |
Goldstein, NH | 1 |
Gall, SA; Gibbs, RS; Hemsell, DL; Knuppel, RA; Lane, TW; Miller, RD; Newton, ER; Poindexter, AN; Reguero, W; Sweet, RL | 1 |
Boswick, JA; Duma, RJ; Echols, RM; Jemsek, JG; Lerner, R; Lewis, RT; Najem, AZ; Press, RA; Rittenbury, MS; Wilson, SE | 1 |
Müller, M; Wittmann, DH | 1 |
Avanzini, P; Bigi, M; Chezzi, C; Lecchini, R; Menozzi, M | 1 |
Poindexter, AN; Ritter, M; Sweet, R | 1 |
Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
Jones, RN; Wilson, HW | 1 |
Jaenisch, E; Shah, PM | 1 |
Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
Hagiwara, S; Ide, M; Jimbo, M; Tanaka, N; Umebara, Y; Yamamoto, M | 1 |
6 trial(s) available for moxalactam and cefotetan
Article | Year |
---|---|
Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.
Topics: Adult; Azoles; Cefoperazone; Cefotetan; Chromatography, High Pressure Liquid; Female; Hematocrit; Humans; Infusions, Intravenous; Male; Moxalactam; Tetrazoles | 1989 |
Cephalosporin therapy in intra-abdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Topics: Cefotetan; Cefoxitin; Drug Evaluation; Humans; Moxalactam; Peritonitis; Random Allocation | 1988 |
Analysis of prothrombin time prolongation in North American cefotetan clinical trials: questions and answers.
Topics: Cefotetan; Cefoxitin; Ceftriaxone; Cephamycins; Clinical Trials as Topic; Humans; Hypoprothrombinemias; Moxalactam; Prothrombin Time | 1988 |
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1988 |
Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
Topics: Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Humans; Moxalactam; Peritonitis; Prospective Studies; Random Allocation; Time Factors | 1988 |
Cefotetan in the treatment of obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Drug Tolerance; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1986 |
16 other study(ies) available for moxalactam and cefotetan
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry.
Topics: Adenosine Diphosphate; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Blood Platelet Disorders; Cefotetan; Cefoxitin; Epinephrine; Flow Cytometry; Fluorescein; Fluoresceins; Goats; Humans; Immunoglobulin G; Mice; Moxalactam; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Tetrazoles | 1992 |
[Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
Topics: Cefazolin; Cefmetazole; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Moxalactam | 1989 |
Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety.
Topics: Azoles; Cefoperazone; Cefotetan; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Moxalactam; Population Surveillance; Risk Factors; Tetrazoles | 1988 |
Comparative activity of cefotetan against plasmid-encoded aminoglycoside-resistant enterobacteria strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotetan; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; R Factors | 1988 |
Patient stratification in intra-abdominal infection.
Topics: Aged; Bacteria; Bacterial Infections; Cefotetan; Cefuroxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Peritonitis | 1987 |
In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefotetan; Cefoxitin; Humans; Kinetics; Microbial Sensitivity Tests; Microscopy, Electron; Moxalactam | 1987 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |
Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1983 |
Activity of third-generation cephalosporins in human blood.
Topics: Cefotaxime; Cefotetan; Ceftriaxone; Cephamycins; Escherichia coli; Humans; Moxalactam | 1983 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
Penetration of intravenous antibiotics into brain abscesses.
Topics: Adult; Aged; Biomarkers; Brain Abscess; C-Reactive Protein; Cefotetan; Child; Combined Modality Therapy; Craniotomy; Empyema, Subdural; Female; Humans; Infant; Inflammation; Inhalation; Leukocyte Count; Male; Middle Aged; Moxalactam; Suppuration; Treatment Outcome | 1993 |
Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotetan; Cefoxitin; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Moxalactam | 1989 |